Yan Sun

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Statistics in medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Hartmut Döhner, Keith W Pratz, Courtney D D DiNardo, Andrew H Wei, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Christian Recher, Andre C Schuh, Sunil Babu, Xiaotong Li, Grace Ku, Zihuan Liu, Yan Sun, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A Pollyea
Genetic Risk Stratification and Outcomes Among Treatment-Naive Patients With AML Treated With Venetoclax and Azacitidine. Blood (2024)
Daniel A Pollyea, Keith W Pratz, Andrew H Wei, Vinod A Pullarkat, Brian A Jonas, Christian Recher, Sunil Babu, Andre C Schuh, Monique Dail, Yan Sun, Jalaja Potluri, Brenda J Chyla, Courtney D D DiNardo
Outcomes in Patients With Poor-risk Cytogenetics With or Without TP53 Mutations Treated With Venetoclax and Azacitidine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Xin Huang, Lu Tian, Yan Sun, Saptarshi Chatterjee, Viswanath Devanarayan
Predictive signature development based on maximizing the area between receiver operating characteristic curves. Statistics in medicine 41 (26) (2022)
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Bergeron, Stephen Ting, JingZhou Hou, Achilles Anagnostopoulos, Andrew McDonald, Vidhya Murthy, Takahiro Yamauchi, Jian-Xiang Wang, Qi Jiang, Yan Sun, Brenda Chyla, Wellington L Mendes, Courtney D D DiNardo
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood (2022)